Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21
Phase 31

Trial Status

Completed1
Recruiting1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05382728Phase 3Recruiting
Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)
EGFR Activating MutationNSCLC
PrincipalinvestigatorStart date: 2022-06-08
NCT04646330Phase 1/2Completed
A Trial of AK104 Plus Anlotinib in NSCLC
NSCLC
PrincipalinvestigatorStart date: 2020-11-18

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Hunan Cancer Hospital

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05382728Phase 3PrincipalInvestigator

Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)

EGFR Activating MutationNSCLC
Recruiting
NCT04646330Phase 1/2PrincipalInvestigator

A Trial of AK104 Plus Anlotinib in NSCLC

NSCLC
Completed

All 2 trials loaded